IL245363B - Cell lines and processes for viral vector manufacture - Google Patents

Cell lines and processes for viral vector manufacture

Info

Publication number
IL245363B
IL245363B IL245363A IL24536316A IL245363B IL 245363 B IL245363 B IL 245363B IL 245363 A IL245363 A IL 245363A IL 24536316 A IL24536316 A IL 24536316A IL 245363 B IL245363 B IL 245363B
Authority
IL
Israel
Prior art keywords
cell lines
viral vector
production methods
vector production
methods
Prior art date
Application number
IL245363A
Other languages
English (en)
Hebrew (he)
Other versions
IL245363A0 (en
Original Assignee
Sementis Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013904242A external-priority patent/AU2013904242A0/en
Application filed by Sementis Ltd filed Critical Sementis Ltd
Publication of IL245363A0 publication Critical patent/IL245363A0/en
Publication of IL245363B publication Critical patent/IL245363B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24151Methods of production or purification of viral material
    • C12N2710/24152Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL245363A 2013-11-01 2016-05-01 Cell lines and processes for viral vector manufacture IL245363B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AU2013904242A AU2013904242A0 (en) 2013-11-01 Viral vector manufacture
AU2014900370A AU2014900370A0 (en) 2014-02-07 Orthopox vectors and propagation
PCT/AU2014/050330 WO2015061858A1 (en) 2013-11-01 2014-11-03 Viral vector manufacture

Publications (2)

Publication Number Publication Date
IL245363A0 IL245363A0 (en) 2016-06-30
IL245363B true IL245363B (en) 2020-01-30

Family

ID=53003022

Family Applications (1)

Application Number Title Priority Date Filing Date
IL245363A IL245363B (en) 2013-11-01 2016-05-01 Cell lines and processes for viral vector manufacture

Country Status (25)

Country Link
US (2) US10544397B2 (https=)
EP (2) EP3375882B1 (https=)
JP (2) JP6682443B2 (https=)
KR (1) KR102047030B1 (https=)
CN (1) CN106255758B (https=)
AU (1) AU2014344738B2 (https=)
CA (1) CA2931518C (https=)
CY (1) CY1121414T1 (https=)
DK (2) DK3063278T3 (https=)
ES (1) ES2670034T3 (https=)
HR (1) HRP20180789T1 (https=)
HU (1) HUE037718T2 (https=)
IL (1) IL245363B (https=)
LT (1) LT3063278T (https=)
NO (1) NO3063278T3 (https=)
NZ (1) NZ720241A (https=)
PL (1) PL3063278T3 (https=)
PT (1) PT3063278T (https=)
RS (1) RS57290B1 (https=)
RU (1) RU2658487C2 (https=)
SG (1) SG11201603919XA (https=)
SI (1) SI3063278T1 (https=)
SM (1) SMT201800267T1 (https=)
TR (1) TR201807128T4 (https=)
WO (1) WO2015061858A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL264893B (en) * 2016-08-19 2022-08-01 Sementis Ltd Vaccines for viruses
JP2018081568A (ja) * 2016-11-17 2018-05-24 グローリー株式会社 紙幣収納装置および紙幣処理機
IL295154A (en) * 2020-01-28 2022-09-01 Lonza Walkersville Inc Methods for determining viral titer
EP4547689A1 (en) * 2022-06-30 2025-05-07 Bavarian Nordic A/S Mammalian cell line for the production of modified vaccinia virus ankara (mva)
WO2024064608A2 (en) * 2022-09-20 2024-03-28 Intergalactic Therapeutics, Inc. Best1 vectors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604183B1 (fr) 1986-09-23 1988-12-30 Transgene Sa Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho
ATE298370T1 (de) 1994-04-29 2005-07-15 Baxter Healthcare Sa Rekombinante poxviren mit fremdenpolynukleotiden in wichtigen regionen
WO2004015118A1 (en) * 2002-08-07 2004-02-19 Bavarian Nordic A/S Vaccinia virus host range genes to increase the titer of avipoxviruses
FR2884255B1 (fr) * 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
CA2658301A1 (en) * 2006-08-04 2008-02-07 Dublin City University A method of producing recombinant biological products

Also Published As

Publication number Publication date
CN106255758A (zh) 2016-12-21
ES2670034T3 (es) 2018-05-29
WO2015061858A1 (en) 2015-05-07
AU2014344738B2 (en) 2019-03-21
CY1121414T1 (el) 2020-05-29
DK3063278T3 (en) 2018-06-06
EP3063278B1 (en) 2018-02-28
PT3063278T (pt) 2018-05-25
KR102047030B1 (ko) 2019-11-20
RU2016121425A (ru) 2017-12-04
JP6682443B2 (ja) 2020-04-15
US10544397B2 (en) 2020-01-28
DK3375882T3 (da) 2019-12-16
HUE037718T2 (hu) 2018-09-28
JP2020039340A (ja) 2020-03-19
IL245363A0 (en) 2016-06-30
EP3375882A1 (en) 2018-09-19
SG11201603919XA (en) 2016-07-28
PL3063278T3 (pl) 2018-08-31
AU2014344738A1 (en) 2016-06-09
US20170029784A1 (en) 2017-02-02
SMT201800267T1 (it) 2018-07-17
NO3063278T3 (https=) 2018-07-28
EP3375882B1 (en) 2019-10-16
NZ720241A (en) 2019-10-25
KR20160079868A (ko) 2016-07-06
HRP20180789T1 (hr) 2018-09-07
RU2658487C2 (ru) 2018-06-21
CA2931518C (en) 2021-03-09
EP3063278A4 (en) 2017-04-12
LT3063278T (lt) 2018-07-10
HK1223395A1 (en) 2017-07-28
SI3063278T1 (sl) 2019-04-30
JP2016534755A (ja) 2016-11-10
US20200190482A1 (en) 2020-06-18
RS57290B1 (sr) 2018-08-31
EP3063278A1 (en) 2016-09-07
CA2931518A1 (en) 2015-05-07
TR201807128T4 (tr) 2018-06-21
CN106255758B (zh) 2020-06-23

Similar Documents

Publication Publication Date Title
IL245573B (en) Cell
IL245720A0 (en) Power generation systems and methods regarding same
DK3812453T3 (da) Metabolisk optimeret cellkultur
PL3083969T3 (pl) Układ do wytwarzania wektorów wirusowych
DK3043784T3 (da) Arylethere og anvendelser deraf
BR112015016219A2 (pt) alto - falante
BR302013004852S1 (pt) Configuração aplicada em auto-falante
DK2962100T3 (da) Tuberkulosebiomarkører og anvendelser deraf
EP3066193C0 (en) CELL CULTURE PROCESS
DK2943561T3 (da) Fotobioreaktor
IL252801A0 (en) Energy extraction system and methods
IL245363B (en) Cell lines and processes for viral vector manufacture
EP3031897A4 (en) Culture vessel
EP3062822C0 (en) CELL TRANSPORT
EP2991616A4 (en) polyplexes
FI10737U1 (fi) Matemaattiset opetusvälineet
BR302013002297S1 (pt) Configuração introduzida em bisnaga
BR302013002005S1 (pt) Configuração introduziada em bombona
BR302013006566S1 (pt) Configuração aplicada em manopla
TH1401006300A (th) กระบวนการหมัก
BR302013004931S1 (pt) Configuração aplicada em manopla
BR302013006179S1 (pt) Configuração aplicada em embarcação
BR302013005554S1 (pt) Configuração aplicada em embarcação
BR302013005167S1 (pt) Configuração aplicada em embarcação
UA28899S (uk) Акумулятор

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed